King Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Dec 07 | Dec 06 | Dec 05 |
|---|---|---|---|
| Current Assets | |||
| Cash | 1,366.1 | 1,004.0 | 655.1 |
| Net Receivables | 304.0 | 347.5 | 305.4 |
| Inventories | 110.3 | 215.5 | 228.1 |
| Other Current Assets | 39.2 | 106.6 | 59.3 |
| Total Current Assets | 1,819.7 | 1,673.5 | 1,247.8 |
| Net Fixed Assets | 257.1 | 307.0 | 302.5 |
| Other Noncurrent Assets | 1,350.1 | 1,349.0 | 1,415.0 |
| Total Assets | 3,426.8 | 3,329.5 | 2,965.2 |
| Liabilities and Shareholder's Equity | Dec 07 | Dec 06 | Dec 05 |
| Current Liabilities | |||
| Accounts Payable | 453.1 | 617.8 | 626.5 |
| Short-Term Debt | -- | -- | 345.0 |
| Other Current Liabilities | -- | -- | -- |
| Total Current Liabilities | 453.1 | 617.8 | 971.5 |
| Long-Term Debt | 400.0 | 400.0 | -- |
| Other Noncurrent Liabilities | 63.0 | 23.1 | 20.4 |
| Total Liabilities | 916.1 | 1,040.9 | 991.8 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 2,510.8 | 2,288.6 | 1,973.4 |
| Total Equity | 2,510.8 | 2,288.6 | 1,973.4 |
| Shares Outstanding (mil.) | 245.9 | 243.2 | 242.1 |






